Skip to main content
Erschienen in: International Journal of Hematology 2/2018

29.01.2018 | Case Report

Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall

verfasst von: Taro Mohri, Yoshihiro Ikura, Asako Hirakoso, Masashi Okamoto, Masakatsu Hishizawa, Akifumi Takaori-Kondo, Seiichi Kato, Shigeo Nakamura, Kai Yoshimura, Hidetoshi Okabe, Yasuhiro Iwai

Erschienen in: International Journal of Hematology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

We report a case of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder (HL-PTLD) after kidney transplantation to highlight the difficulty of distinguishing this disorder from Hodgkin lymphoma-like PTLD (HL-like PTLD). Through this case report and literature review, we seek to clarify definitive pathologic features to differentiate these two conditions. A 38-year-old male kidney transplant recipient who had been receiving immunosuppressants was admitted to our hospital with unidentified high fever. Computed tomography images and blood tests indicated a lymphoproliferative disorder. Abdominal lymph node biopsy was performed, and microscopic examination revealed the presence of many large atypical cells in a background of dense T cell accumulation. The large, atypical cells were positive for Epstein–Barr Virus (EBV)-encoded small RNAs (EBER) in situ hybridization, EBV-LMP1, CD30 and PAX5, but negative for CD15, CD20 and CD45. Except for CD15-negativity, this immunohistochemical pattern was consistent with that of classical Hodgkin lymphoma. By close examination of the above immunoreactivities and the patient’s subsequent chemosensitive clinical course, we finally made a diagnosis of HL-PTLD.
Literatur
1.
Zurück zum Zitat Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 453–62. Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 453–62.
2.
Zurück zum Zitat Ranganathan S, Webber S, Ahuja S, Jaffe R. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma? Pediatr Dev Pathol. 2004;7:348–60.PubMed Ranganathan S, Webber S, Ahuja S, Jaffe R. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma? Pediatr Dev Pathol. 2004;7:348–60.PubMed
3.
Zurück zum Zitat Rohr JC, Wagner HJ, Lauten M, Wacker HH, Jüttner E, Hanke C, et al. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatr Transpl. 2008;12:426–31.CrossRef Rohr JC, Wagner HJ, Lauten M, Wacker HH, Jüttner E, Hanke C, et al. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatr Transpl. 2008;12:426–31.CrossRef
4.
Zurück zum Zitat Pitman SD, Huang Q, Zuppan CW, Rowsell EH, Cao JD, Berdeja JG, et al. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am J Surg Pathol. 2006;30:470–6.CrossRefPubMed Pitman SD, Huang Q, Zuppan CW, Rowsell EH, Cao JD, Berdeja JG, et al. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am J Surg Pathol. 2006;30:470–6.CrossRefPubMed
5.
Zurück zum Zitat Oldhafer KJ, Bunzendahl H, Frei U, Kemnitz J, Vogt P, Pichlmayr R. Primary Hodgkin’s lymphoma: an unusual cause of graft dysfunction after kidney transplantation. Am J Med. 1989;87:218–20.CrossRefPubMed Oldhafer KJ, Bunzendahl H, Frei U, Kemnitz J, Vogt P, Pichlmayr R. Primary Hodgkin’s lymphoma: an unusual cause of graft dysfunction after kidney transplantation. Am J Med. 1989;87:218–20.CrossRefPubMed
6.
Zurück zum Zitat Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer. 1993;72:2568–73.CrossRefPubMed Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer. 1993;72:2568–73.CrossRefPubMed
7.
Zurück zum Zitat Goyal RK, McEvoy L, Wilson DB. Hodgkin disease after renal transplantation in childhood. J Pediatr Hematol Oncol. 1996;18:392–5.CrossRefPubMed Goyal RK, McEvoy L, Wilson DB. Hodgkin disease after renal transplantation in childhood. J Pediatr Hematol Oncol. 1996;18:392–5.CrossRefPubMed
8.
Zurück zum Zitat Lister J, Simpson JK, deMagalhaes-Silverman MM, Rybka WB, Donnenberg AD, Myers DJ, et al. Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years. Bone Marrow Transpl. 1997;19:943–5.CrossRef Lister J, Simpson JK, deMagalhaes-Silverman MM, Rybka WB, Donnenberg AD, Myers DJ, et al. Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years. Bone Marrow Transpl. 1997;19:943–5.CrossRef
9.
Zurück zum Zitat Chetty R, Biddolph S, Gatter K. An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin’s disease and Reed-Sternberg-like cells in non-Hodgkin’s lymphomas and reactive conditions. Hum Pathol. 1997;28:493–8.CrossRefPubMed Chetty R, Biddolph S, Gatter K. An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin’s disease and Reed-Sternberg-like cells in non-Hodgkin’s lymphomas and reactive conditions. Hum Pathol. 1997;28:493–8.CrossRefPubMed
10.
Zurück zum Zitat Dharnidharka VR, Douglas VK, Hunger SP, Fennell RS. Hodgkin’s lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transpl. 2004;8:87–90.CrossRef Dharnidharka VR, Douglas VK, Hunger SP, Fennell RS. Hodgkin’s lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transpl. 2004;8:87–90.CrossRef
11.
Zurück zum Zitat Zambelli A, Lilleri D, Baldanti F, Scelsi M, Villani L, Da Prada GA. Hodgkin’s disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma. BMC Cancer. 2005;5:109.CrossRefPubMedPubMedCentral Zambelli A, Lilleri D, Baldanti F, Scelsi M, Villani L, Da Prada GA. Hodgkin’s disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma. BMC Cancer. 2005;5:109.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Choi JH, Ahn MJ, Oh YH, Han SW, Kim HJ, Lee YY, et al. Epstein–Barr virus-associated Hodgkin’s disease following renal transplantation. Korean J Intern Med. 2006;21:46–9.CrossRefPubMedPubMedCentral Choi JH, Ahn MJ, Oh YH, Han SW, Kim HJ, Lee YY, et al. Epstein–Barr virus-associated Hodgkin’s disease following renal transplantation. Korean J Intern Med. 2006;21:46–9.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Gheorghe G, Albano EA, Porter CC, McGavran L, Wei Q, Meltesen L, et al. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature. J Pediatr Hematol Oncol. 2007;29:112–6.CrossRefPubMed Gheorghe G, Albano EA, Porter CC, McGavran L, Wei Q, Meltesen L, et al. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature. J Pediatr Hematol Oncol. 2007;29:112–6.CrossRefPubMed
15.
Zurück zum Zitat Okuno K, Horie Y, Kanai K, Kato M, Kuwamoto S, Okazaki T, et al. Epstein–Barr virus associated post-transplant Hodgkin lymphoma in an adult patient after cord blood stem cell transplantation for acute lymphoblastic leukemia. J Clin Exp Hematop. 2009;49:45–51.CrossRefPubMed Okuno K, Horie Y, Kanai K, Kato M, Kuwamoto S, Okazaki T, et al. Epstein–Barr virus associated post-transplant Hodgkin lymphoma in an adult patient after cord blood stem cell transplantation for acute lymphoblastic leukemia. J Clin Exp Hematop. 2009;49:45–51.CrossRefPubMed
16.
Zurück zum Zitat Krishnamurthy S, Hassan A, Frater JL, Paessler ME, Kreisel FH. Pathologic and clinical features of Hodgkin lymphoma—like posttransplant lymphoproliferative disease. Int J Surg Pathol. 2010;18:278–85.CrossRefPubMed Krishnamurthy S, Hassan A, Frater JL, Paessler ME, Kreisel FH. Pathologic and clinical features of Hodgkin lymphoma—like posttransplant lymphoproliferative disease. Int J Surg Pathol. 2010;18:278–85.CrossRefPubMed
17.
Zurück zum Zitat Yagi T, Ishikawa J, Aono N, Yamashita Y, Kusakabe S, Yoshinami T, et al. Epstein–Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma. Int J Hematol. 2012;95:214–6.CrossRefPubMed Yagi T, Ishikawa J, Aono N, Yamashita Y, Kusakabe S, Yoshinami T, et al. Epstein–Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma. Int J Hematol. 2012;95:214–6.CrossRefPubMed
18.
Zurück zum Zitat Basso S, Zecca M, Calafiore L, Rubert L, Fiocchi R, Paulli M, et al. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein–Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. Pediatr Transpl. 2013;17:E168–73.CrossRef Basso S, Zecca M, Calafiore L, Rubert L, Fiocchi R, Paulli M, et al. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein–Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. Pediatr Transpl. 2013;17:E168–73.CrossRef
19.
Zurück zum Zitat Salh OS, Nadhem ON, Thakore SR, Halloush RA, Khasawneh FA. A 47-year-old stem cell transplant recipient with fever, cough and chest pain. Can Respir J. 2015;22:144–6.CrossRefPubMedPubMedCentral Salh OS, Nadhem ON, Thakore SR, Halloush RA, Khasawneh FA. A 47-year-old stem cell transplant recipient with fever, cough and chest pain. Can Respir J. 2015;22:144–6.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Le J, Durand CM, Agha I, Brennan DC. Epstein–Barr virus and renal transplantation. Transpl Rev (Orlando). 2017;31:55–60.CrossRef Le J, Durand CM, Agha I, Brennan DC. Epstein–Barr virus and renal transplantation. Transpl Rev (Orlando). 2017;31:55–60.CrossRef
21.
Zurück zum Zitat Holman CJ, Karger AB, Mullan BD, Brundage RC, Balfour HH Jr. Quantitative Epstein–Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder. Clin Transpl. 2012;26:741–7.CrossRef Holman CJ, Karger AB, Mullan BD, Brundage RC, Balfour HH Jr. Quantitative Epstein–Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder. Clin Transpl. 2012;26:741–7.CrossRef
22.
Zurück zum Zitat Stein H, Pileri SA, Weiss LM, Poppema S, Gascoyne RD, Jaffe ES. Hodgkin lymphomas, introduction. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 424–30. Stein H, Pileri SA, Weiss LM, Poppema S, Gascoyne RD, Jaffe ES. Hodgkin lymphomas, introduction. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 424–30.
23.
Zurück zum Zitat Adams H, Liebisch P, Schmid P, Dirnhofer S, Tzankov A. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms. Appl Immunohistochem Mol Morphol. 2009;17:96–101.CrossRefPubMed Adams H, Liebisch P, Schmid P, Dirnhofer S, Tzankov A. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms. Appl Immunohistochem Mol Morphol. 2009;17:96–101.CrossRefPubMed
24.
Zurück zum Zitat Jiang Y, Chen Y, Huang R, Chen G. Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis. Int J Hematol. 2016;104:413–9.CrossRefPubMed Jiang Y, Chen Y, Huang R, Chen G. Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis. Int J Hematol. 2016;104:413–9.CrossRefPubMed
25.
Zurück zum Zitat Hernandez O, Oweity T, Ibrahim S. Is an increase in CD4/CD8 T-cell ratio in lymph node fine needle aspiration helpful for diagnosing Hodgkin lymphoma? A study of 85 lymph node FNAs with increased CD4/CD8 ratio. Cytojournal. 2005;2:14.CrossRefPubMedPubMedCentral Hernandez O, Oweity T, Ibrahim S. Is an increase in CD4/CD8 T-cell ratio in lymph node fine needle aspiration helpful for diagnosing Hodgkin lymphoma? A study of 85 lymph node FNAs with increased CD4/CD8 ratio. Cytojournal. 2005;2:14.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Roshal M, Wood BL, Fromm JR. Flow cytometric detection of the classical Hodgkin lymphoma: clinical and research applications. Adv Hematol. 2011;2011:387034.CrossRefPubMed Roshal M, Wood BL, Fromm JR. Flow cytometric detection of the classical Hodgkin lymphoma: clinical and research applications. Adv Hematol. 2011;2011:387034.CrossRefPubMed
Metadaten
Titel
Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall
verfasst von
Taro Mohri
Yoshihiro Ikura
Asako Hirakoso
Masashi Okamoto
Masakatsu Hishizawa
Akifumi Takaori-Kondo
Seiichi Kato
Shigeo Nakamura
Kai Yoshimura
Hidetoshi Okabe
Yasuhiro Iwai
Publikationsdatum
29.01.2018
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 2/2018
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-2410-x

Weitere Artikel der Ausgabe 2/2018

International Journal of Hematology 2/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.